• 1. Aluminium alkyl and aryloxide complexes of pyrazine and bipyridines: synthesis and structure?
  Doug Ogrin,Laura H. van Poppel,Simon G. Bott,Andrew R. Barron Dalton Trans., 2004, 3689-3694
• 2. Aggregation-induced chiral symmetry breaking of a naphthalimide–cyanostilbene dyad?
  Xin Li,Liangliang Zhu,Sai Duan,Yanli Zhao,Hans ?gren Phys. Chem. Chem. Phys., 2014,16, 23854-23860
• 3. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

Introduction to (2E)-3-quinolin-8-ylacrylic Acid (CAS No. 77377-27-6)

(2E-3-quinolin-8-ylacrylic Acid) is a significant compound in the realm of chemical and pharmaceutical research, characterized by its unique structural and functional properties. This compound, identified by the CAS number 77377-27-6, has garnered considerable attention due to its potential applications in various scientific domains.

The molecular structure of (2E-3-quinolin-8-ylacrylic Acid) consists of a quinoline moiety linked to an acrylic acid backbone. This configuration endows the compound with distinctive reactivity and binding capabilities, making it a valuable scaffold for drug design and synthesis. The quinoline ring, a well-known pharmacophore, is extensively studied for its antimicrobial, antimalarial, and anticancer properties. When combined with the acrylic acid moiety, the compound exhibits enhanced solubility and bioavailability, which are critical factors in pharmaceutical development.

In recent years, (2E-3-quinolin-8-ylacrylic Acid) has been explored in the context of innovative therapeutic strategies. Researchers have been particularly interested in its potential as a precursor for the development of novel anticancer agents. The quinoline moiety interacts with biological targets such as topoisomerases and kinases, which are essential for cancer cell proliferation. Additionally, the acrylic acid group facilitates further chemical modifications, allowing for the creation of derivatives with tailored pharmacological profiles.

One of the most compelling aspects of (2E-3-quinolin-8-ylacrylic Acid) is its role in the synthesis of small-molecule inhibitors. These inhibitors have shown promise in preclinical studies for targeting specific pathways involved in tumor growth and metastasis. For instance, studies have demonstrated that derivatives of this compound can disrupt microtubule formation, thereby inhibiting cancer cell division. The ability to modulate these pathways highlights the therapeutic potential of (2E-3-quinolin-8-ylacrylic Acid) as a lead compound in oncology research.

Beyond oncology, (2E-3-quinolin-8-ylacrylic Acid) has been investigated for its antimicrobial properties. The quinoline scaffold is known to exhibit activity against a range of pathogens, including bacteria and fungi. This has led to explorations into using this compound as a component in antimicrobial coatings and formulations. The acrylic acid group further enhances its antimicrobial efficacy by facilitating interactions with microbial cell membranes, leading to cell lysis and death.

The synthesis of (2E-3-quinolin-8-ylacrylic Acid) involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, such as palladium-catalyzed cross-coupling reactions and asymmetric hydrogenation, have been employed to achieve high yields and enantioselectivity. These techniques are crucial for producing enantiomerically pure forms of the compound, which are often necessary for optimal biological activity.

In conclusion, (2E-3-quinolin-8-ylacrylic Acid) represents a fascinating compound with diverse applications in pharmaceutical research. Its unique structural features and biological activities make it a promising candidate for developing new therapeutic agents. As research continues to uncover new insights into its mechanisms of action, the potential applications of this compound are expected to expand further, contributing to advancements in medicine and biotechnology.

• 29953-71-7(trans-3-Indoleacrylic Acid)
• 288371-43-7((2E)-3-(1H-indol-7-yl)prop-2-enoic acid)
• 1204-06-4(3-Indoleacrylic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)